Article

(2021) A randomized clinical trial evaluating the immunomodulatory effect of convalescent plasma on COVID-19-related cytokine storm. Internal and Emergency Medicine. pp. 2181-2191. ISSN 1828-0447

(2020) Clinical efficacy of convalescent plasma for treatment of COVID-19 infections: Results of a multicenter clinical study. Transfusion and Apheresis Science. p. 5. ISSN 1473-0502

(2020) Management of COVID-19 Virus Infection by Convalescent Plasma. Iranian Journal of Allergy Asthma and Immunology. pp. 3-6. ISSN 1735-1502

(2018) Comparative evaluation of the safety and efficacy of recombinant FVIII in severe hemophilia A patients. Journal of Pharmacopuncture. pp. 76-81. ISSN 2093-6966

(2016) Cost components of treatment protocols of haemophilia patients with inhibitors using bypassing agents in Iran. Iranian Journal of Pharmaceutical Sciences. pp. 85-90. ISSN 17352444 (ISSN)

(2016) Cost-Effectiveness Analysis of Biogeneric Recombinant Activated Factor VII (AryoSeven (TM)) and Activated Prothrombin Complex Concentrates (FEIBA (TM)) to Treat Hemophilia A Patients with Inhibitors in Iran. Iranian Journal of Pharmaceutical Research. pp. 669-677. ISSN 1735-0328

(2016) Health care resource utilization and cost of care for haemophilia A and B patients in Iran. Transfusion and Apheresis Science. pp. 122-126. ISSN 1473-0502

(2015) A prospective crossover triple-blind controlled trial on the safety and efficacy of Iranian recombinant FVIII (Safacto®) versus plasma derived FVIII; a pilot study. Iranian Journal of Blood and Cancer. pp. 171-174. ISSN 20084595 (ISSN)

(2014) Comparison of Bypassing Agents in Bleeding Reduction in Treatment of Bleeding Episodes in Patients With Haemophilia and Inhibitors. Iranian Red Crescent Medical Journal. p. 6. ISSN 2074-1804

(2012) Cost Assessment of Implementation of ITI in Iran. Haemophilia. p. 68. ISSN 1351-8216

(2012) Cost Assessment of Implementation of Immune Tolerance Induction in Iran. Value Health Reg Issues. pp. 54-58. ISSN 2212-1099

(2011) Social consequences of infected haemophilia cases in the Islamic Republic of Iran. Eastern Mediterranean Health Journal. pp. 552-556. ISSN 10203397 (ISSN)

(2004) Factor XIII deficiency in south-east Iran. Haemophilia. pp. 470-472. ISSN 1351-8216